Core Viewpoint - *ST Zhongcheng (formerly Qingdao Zhongcheng) has exhibited systematic, persistent, and cross-border characteristics in its financial fraud activities since 2017, involving fabricated projects and inflated asset values across two continents in the renewable energy and mineral resources sectors [1][2]. Group 1: Financial Fraud Details - The company inflated revenue by 1.403 billion yuan (92.18% of revenue) and profit by 553 million yuan (136.17% of profit) through premature recognition of uncompleted engineering income in the Philippines wind power project from 2017 to 2021 [1]. - In 2019, the company manipulated its financials by reducing revenue by 672 million yuan (88.83% of revenue) to adjust profit indicators, showcasing a typical "big bath" accounting strategy [1]. - From 2020 to 2022, despite knowing the revocation of mining rights and expiration of mining licenses, the company falsely listed invalid mining rights as intangible assets, cumulatively inflating asset size by over 1 billion yuan [2]. Group 2: Concealment of Major Litigation - In 2023, the company concealed a significant lawsuit involving 627 million yuan (57.47% of 2022 net assets) for six months, with collective participation from senior management in information suppression, indicating "institutional fraud" [3]. - The regulatory response included a fine of 7.5 million yuan for the company and a 6.5 million yuan fine plus a 10-year market ban for the main responsible person, totaling 19 million yuan in penalties, reflecting a shift towards a comprehensive punitive system [3]. Group 3: Potential Delisting - The delisting path for *ST Zhongcheng is characterized by intersecting regulatory triggers, including a negative net asset warning by the end of 2023 and a qualified audit report in 2024, which could lead to termination of listing [4]. - The company has faced compounded delisting risks due to six consecutive years of fraud, meeting the criteria for "three years of fraud leading to delisting" [4]. - Despite efforts from Qingdao state-owned assets to stabilize the company, including a debt waiver of 850 million yuan, the company still reported a 70.21% year-on-year revenue decline to 137 million yuan and a net loss of 310 million yuan in 2024, highlighting management failures in cross-border resource development [4].

Group 1: Company Performance and Risk Management - The company aims to consolidate existing business and clients while actively developing new ones to improve performance and avoid delisting risks [1][2] - Measures are being taken to enhance internal control management and ensure sustainable operational capabilities to eliminate delisting risks [2] - The company is optimistic about achieving a revenue target of 300 million this year despite restrictions on military procurement [2] Group 2: Strategic Planning and Investments - The company is exploring acquisition opportunities to mitigate the impact of the suspension of operations at its subsidiary, Dajiang Metal [3] - There are ongoing discussions regarding potential mergers and acquisitions that will be disclosed in accordance with regulatory requirements [4] - The company is committed to providing updates on any relevant acquisition targets as they arise [3][4] Group 3: Financial Outlook and Reporting - The company is focused on improving its gross profit margins, particularly in the metal products sector, to enhance overall performance [4] - Future plans and restructuring efforts will be communicated through official channels, ensuring transparency with investors [4]

证券代码：600190/900952 证券简称：*ST 锦港/*ST 锦港 B 公告编号：2025-050 锦州港股份有限公司 关于公司可能存在因股价低于1元而终止上市的 ?锦州港股份有限公司（以下简称"公司"）股票 2025 年 5 月 19 日收盘价 已连续 10 个交易日低于 1 元，其中 A 股收盘价为 0.92 元/股，B 股收盘价为 0.047 美元/股。根据《上海证券交易所股票上市规则》 （以下简称"《股票上市规则》"） 第 9.2.1 条第一款第三项规定，在上海证券交易所（以下简称"上交所"）既发 行 A 股股票又发行 B 股股票的上市公司，如果 A、B 股股票连续 20 个交易日的每 日股票收盘价均低于 1 元，公司股票可能被上交所终止上市交易，属于交易类强 制退市。根据《股票上市规则》第 9.6.1 条第二款规定，交易类强制退市公司股 票不进入退市整理期交易。敬请广大投资者注意投资风险。 ?公司于 2025 年 4 月 29 日收到中国证券监督管理委员会（以下简称"中国 证监会"）《行政处罚及市场禁入事先告知书》（【2025】1 号，以下简称"《事先 告知书》"），显示公司触及重大违法强制 ...

证券代码：600190/900952 证券简称：*ST锦港/*ST锦港B 公告编号：2025-051 锦州港股份有限公司 关于实施其他风险警示的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重大风险提示： ?截至本公告披露日，锦州港股份有限公司（以下简称"公司"）存在三种 叠加实施其他风险警示的情形：一是，公司存在违规对外提供担保且未能在 1 个 月内完成整改的情形；二是，中审众环会计师事务所（特殊普通合伙）（以下简 称"中审众环"）对公司 2024 年度财务报告内部控制出具了否定意见的审计报告； 三是，根据中国证监会《行政处罚及市场禁入事先告知书》（处罚字【2024】59 号）及《行政处罚决定书》(〔2024〕96 号)载明的事实，公司披露的 2018 年至 条第（一）、 （三）、 （七）项规定的其他风险警示情形，公司股票已被上交所叠加 实施其他风险警示。 ?公司于2025年4月29日收到中国证券监督管理委员会（以下简称"中国证监 会"） 《行政处罚及市场禁入事先告知书》 （【2025】1号，以下简称" 截至本公 ...

记者｜赵阳戈 2024年年报披露后，*ST中程（300208.SZ）收到了来自深交所的《终止上市事先告知书》，原因在于 公司2024年度财务会计报告被出具了保留意见的审计报告，以及内部控制被出具了否定意见的审计报 告。 值得注意的是，*ST中程对审计得出的结论并不认可，甚至指摘对方办事不力、推卸责任。如今公司已 在申请听证的路上。 源：公告 光伏项目上，审计在推卸责任？ 根据《终止上市事先告知书》内容，*ST中程曾因2023年度经审计的期末净资产为负值，被实施退市风 险警示。一年后的2025年4月30日，*ST中程2024年度财务会计报告被出具了保留意见的审计报告，内 部控制被出具了否定意见的审计报告。如此表现自是触发了终止上市的相关规则。 *ST中程与审计机构的争议的焦点之一在于菲律宾光伏项目。 *ST中程2016年11月承接菲律宾风光一体化EPC项目，2017年开始建设，至今近8年，截至2024年12月31 日，项目仍未交付并网。2025年4月15日，*ST中程向业主方移交菲律宾光伏项目并签署《风电(132兆 瓦)-光伏(100兆瓦)风光一体项目之结算协议》和《质押协议》，结算金额为2.12亿美元(按去年 ...

Core Viewpoint - Jiangsu Wuzhong (ST Suwu) is facing significant challenges, including a recent investigation by the China Securities Regulatory Commission (CSRC) and potential delisting risks, despite a brief turnaround in 2024 due to the successful launch of its product "AestheFill" [1][2][3][6]. Group 1: Financial Performance - Jiangsu Wuzhong reported a net profit of approximately 70.48 million yuan in 2024, primarily driven by the sales of "AestheFill," which sold around 20,000 units in the first two months post-launch, generating a gross profit of 66.41 million yuan [6]. - The company experienced a revenue decline of 28.64% year-on-year in 2024, with total revenue around 1.599 billion yuan, attributed to decreased pharmaceutical and trade income [6]. - In Q1 2024, the medical beauty business generated approximately 113 million yuan in revenue, marking a staggering year-on-year growth of 8781.59%, while the pharmaceutical segment saw a 52.51% decline in revenue [7]. Group 2: Regulatory Issues - The chairman of Jiangsu Wuzhong, Qian Qunshan, is under investigation by the CSRC for suspected violations of information disclosure laws, which has led to a significant drop in stock price [2][3]. - The company received an adverse audit opinion for its 2024 financial report due to issues related to overdue receivables and criminal liability for assisting in tax fraud, resulting in a risk warning and a change in stock designation to "*ST Suwu" [3][4]. - If the CSRC concludes that the company has committed major violations, it may face mandatory delisting under the Shanghai Stock Exchange rules [2]. Group 3: Competitive Landscape - Jiangsu Wuzhong's exclusive agency rights for "AestheFill" are in jeopardy as a competitor, Aimeike, has acquired 85% of the product's parent company, Regen, for approximately 1.373 billion yuan, raising concerns about the sustainability of its market position [8]. - The company previously stated that its rights to "AestheFill" are limited to a certain period and do not include ownership or production rights [8].

Group 1 - The company *ST Yushun has announced a risk of being delisted due to a net loss of 17.57 million yuan for the fiscal year 2024, with a net loss of 21.43 million yuan after excluding non-recurring gains and losses [2] - The company's operating revenue for 2024 was 220 million yuan, which is below the 300 million yuan threshold, triggering delisting risk warnings effective from May 6, 2025 [2] - The company is planning to acquire 100% equity of three companies, including Zhong'en Cloud (Beijing) Data Technology Co., Ltd., which may constitute a major asset restructuring, but the transaction is still in the planning stage and faces approval risks [2] Group 2 - As of the end of Q1 2025, the company had a cash balance of 14.50 million yuan and total liabilities of 155 million yuan, indicating potential negative impacts on operational performance if sufficient transaction funds cannot be raised [2] - The company’s customer concentration is high, and any changes in demand from key customers or difficulties in acquiring new clients could adversely affect its performance [2] - As of May 15, 2025, the company's price-to-book ratio was 16.07 times, significantly deviating from the industry average price-to-earnings ratio of 37.99 times and price-to-book ratio of 3.22 times for comparable listed companies in the manufacturing sector [3]

证券代码：600190/900952 证券简称：*ST锦港（维权）/*ST锦港B 公告编号：2025-047 锦州港股份有限公司 关于公司股票交易暨退市风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ●锦州港股份有限公司（以下简称"公司"）股票已于 2025年5月6日起被实施重大违法类退市风险警示， 今日公司股价盘中大幅上涨，股价波动大。经核，公司不存在应披露未披露事项，敬请广大投资者理性 投资并注意投资风险。 ●公司于2025年4月29日收到中国证券监督管理委员会（以下简称"中国证监会"）《行政处罚事先告知 书》，显示公司触及重大违法强制退市情形，公司股票已于 2025年5月6日起被实施重大违法类退市风 险警示。后续收到行政处罚决定书后，根据其认定的事实，公司股票将被实施重大违法强制退市。 ●截至2025年5月14日，公司A股、B股股票收盘价已连续7个交易日均低于人民币1元。如其A、B股股票 的收盘价同时连续20个交易日的每日股票收盘价均低于1元，公司股票将被终止上市交易。 一、公司存在重大违法 ...

证券代码：600190/900952 证券简称：*ST 锦港/*ST 锦港 B 公告编号：2025-048 锦州港股份有限公司 关于公司股票交易暨退市风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ?2025 年 5 月 15 日，锦州港股份有限公司（以下简称"公司"）股票价格 波动较大，如后续公司股票交易进一步出现重大异常，为保护中小投资者合法权 益，公司将依规申请停牌核查。敬请广大投资者理性投资并注意投资风险。 ?截至 2025 年 5 月 15 日，公司 A 股、B 股股票收盘价已连续 8 个交易日均 低于人民币 1 元。如其 A、B 股股票的收盘价同时连续 20 个交易日的每日股票收 盘价均低于 1 元，公司股票将被终止上市交易。 截至 2025 年 5 月 15 日，公司 A 股、B 股股票收盘价已连续 8 个交易日均低 于人民币 1 元。根据《股票上市规则》第 9.2.1 条第一款第（三）项规定，在上 海证券交易所既发行 A 股股票又发行 B 股股票的上市公司，其 A、B 股股票的收 ...

年报"难产"、审计机构反目、经营困局难解。ST恒立（000622.SZ）的退市危机正迎来"终局时刻"。 新东家入主未满9个月，有"不死鸟"之称的*ST恒立(000622.SZ)再次遭遇退市危机。 *ST恒立5月13日公告称，公司已在规定期限内向深交所提交听证申请。此前，该公司因年报"难产"触发了退市红线。 该公司将年报难产归咎于审计机构，并向后者起诉索赔3827万元。然而，更深层次的问题在于，*ST恒立与审计机构 在部分营业收入确认上存在重大分歧，若相关收入无法计入财报，该公司2024年扣除后的营收可能低于3亿元，触发 退市标准。 目前，*ST恒立虽已提交听证申请，但市场普遍认为，该公司翻盘可能性极低。这家曾多次"披星戴帽"、数度易主的 上市公司，可能终将难逃退市命运。 与审计机构反目年报"难产" *ST恒立退市风险的导火索，是未在法定期限内披露2024年年报。5月6日，证监会已对该公司立案调查。次日，深交 所发出告知书，因未在法定期限内披露过半数董事保证真实、准确、完整的2024年年报，触及了深交所规定的股票终 止上市情形，因此拟决定终止该公司股票上市。目前，*ST恒立已提交听证申请，试图最后一搏。 *ST ...